Roger E. Susi - 17 Feb 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Roger E. Susi
Issuer symbol
IRMD
Transactions as of
17 Feb 2022
Net transactions value
-$471,506
Form type
4
Filing time
22 Feb 2022, 15:10:26 UTC
Previous filing
08 Feb 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale $471,506 -10,000 -1.3% $47.15 732,950 17 Feb 2022 By Roger E. Susi Revocable Trust F1, F2
holding IRMD Common Stock 2,362,500 17 Feb 2022 By Matthew Susi 2008 Dynasty Trust F3
holding IRMD Common Stock 2,362,500 17 Feb 2022 By Phillip Susi 2008 Dynasty Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Roger E. Susi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $46.13 to $48.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.